tiprankstipranks
Unity Biotechnology Inc (DE:9U9)
BERLIN:9U9

Unity Biotechnology (9U9) Financial Statements

0 Followers

Unity Biotechnology Financial Overview

Unity Biotechnology's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Unity Biotechnology is scheduled to report earnings on ―, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement-
Total Revenue$ 236.00K$ 0.00$ 4.78M$ 0.00$ 0.00
Gross Profit-----
EBIT$ -12.24M$ -18.11M$ -9.87M$ -15.66M$ -17.04M
EBITDA$ -11.63M$ -17.48M$ -9.20M$ -14.95M$ -16.30M
Net Income Common Stockholders$ -13.14M$ -18.91M$ -10.69M$ -16.45M$ -17.83M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 64.51M$ 79.16M$ 80.97M$ 83.94M$ 88.08M
Total Assets$ 97.59M$ 112.47M$ 124.71M$ 125.69M$ 136.26M
Total Debt$ 42.19M$ 48.39M$ 53.34M$ 62.04M$ 64.36M
Net Debt$ -22.32M$ -30.77M$ -27.63M$ -21.90M$ -23.71M
Total Liabilities$ 57.66M$ 61.78M$ 65.14M$ 67.95M$ 70.35M
Stockholders Equity$ 39.93M$ 50.69M$ 57.74M$ 59.57M$ 65.92M
Cash Flow-
Free Cash Flow$ -14.85M$ -14.97M$ -5.04M$ -11.65M$ -13.46M
Operating Cash Flow$ -14.84M$ -14.97M$ -5.03M$ -11.56M$ -13.38M
Investing Cash Flow$ 17.69M$ -5.82M$ 9.08M$ 17.15M$ -979.00K
Financing Cash Flow$ 138.00K$ 4.33M$ 6.86M$ 2.90M$ 1.02M
Currency in USD

Unity Biotechnology Earnings and Revenue History

Unity Biotechnology Debt to Assets

Unity Biotechnology Cash Flow

Unity Biotechnology Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis